Delivery Order SPE2DB22D1106-SPE2DB24FEVJ1
- Not listed
- This federal contract award, with an ID of SPE2DB20D3101 and SPE2DB25FRDB7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,437.70 firm fixed-price delivery order is for the supply of 4567409254 CEFPODOXIME 200 MG TABLET 20S, a pharmaceutical product. The contract has an ultimate completion date of February 28, 2025. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,831.98 firm fixed-price delivery order is for the supply of 4567343227 CEFPODOXIME 200 MG TABLET 20S, with a period of performance through February 24, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,150.16, is a delivery order for the supply of 4567178201 CEFPODOXIME 200 MG TABLET 20S. It has an ultimate completion date of February 7, 2025. The contract is a firm fixed-price agreement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of CEFPODOXIME 200 MG TABLET 20S. The $2,687.22 firm fixed price delivery order has a completion date of May 21, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,291.45 firm fixed-price delivery order is for the supply of CEFPODOXIME 200 MG TABLET 20S, a pharmaceutical product. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
- This federal contract award, with a GovTribe ID of SPE2DB22D3004|SPE2DB25FQQ09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,161.06 firm-fixed-price delivery order is for the supply of 4568180910 - CEFPODOXIME 200 MG TABLET 20S. The contract has a period of performance through May 9, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award, valued at $3,555.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of CEFPODOXIME 200 MG TABLET 20S, a pharmaceutical product. The contract has an ultimate completion date of February 20, 2025 and is a firm fixed-price contract. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp, the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,492.31 firm fixed-price delivery order is for the provision of CEFPODOXIME 200 MG TABLET 20S, a prescription medication. The contract has an ultimate completion date of April 1, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, valued at $2,117.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of CEFPODOXIME 200 MG TABLET 20S, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of September 5, 2024. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,523.34 firm fixed-price delivery order contract is for the supply of CEFPODOXIME 100 MG TABLET 20S, a generic medication. The contract has a period of performance through February 20, 2025 and was awarded on February 19, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEVJ1Delivery Order
This federal contract award, with ID SPE2DB22D1106 and SPE2DB24FEVJ1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,856.90 firm fixed-price delivery order is for the procurement of 4564808969 - CEFPODOXIME 200 MG TABLET 20S. The contract has an ultimate completion date of June 6, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the DLA Troop Support Medical program. The company holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated as a set-aside.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 6/5/24 |